Oncotarget

In The News



Life Extension Daily News


2018-04-20
presentation "Artificial Intelligence for Aging Biomarkers & Age Management Research " will focus on the recent advances in machine learning techniques that outperform classical approaches in biomarker development and complex genomics, transcriptomics and proteomics problems. The session will be devoted to the development of aging biomarkers and customer-oriented age-management systems that utilize multiple AI-driven approaches stacked into an ensemble and trained on multiple medical and... continue reading >>


Insilico to present the advances in Artificial Intelligence for African pharmaceutical industry


2018-04-18
Insilico to present the advances in Artificial Intelligence for African pharmaceutical industry InSilico Medicine, Inc. IMAGE: Iraneus Ogu from Insilico Medicine gives a talk at the International Conference on e-Education, e-Business, e-Management and e-Learning (ICEBML-18) in Johannesburg, South Africa. view more Credit: Insilico Medicine Wednesday, April 118th, 2018, Baltimore, MD - Insilico Medicine, a Baltimore-based company specializing in the application of for drug discovery,... continue reading >>


A Look at Microbes in Schizophrenia


2018-04-18
Marked by delusions and hallucinations, schizophrenia is not uncommon . More than 50 million people or 1% of humans suffer with this devastating psychiatric disorder. What causes schizophrenia? Researchers believe that a combination of genetics, brain chemistry and environment contributes to development of the disorder. The gut-brain axis may be one pathway. Risk factors for schizophrenia Family history of schizophrenia Older age of the father Some pregnancy and birth complications ,... continue reading >>


OncoDNA announces publication of peer-reviewed study in Oncotarget assessing the utility of its uniq


2018-04-17
Confessions of a Radiation Oncologist: What you don't know about Cancer and Radiation Therapy. by MD Bobby N. Koneru (Author), Alla Zarifyan (Editor), Carolyn Wittstone (Editor)CONFESSIONS OF A RADIATION ONCOLOGIST: What You Don't Know About Cancer and Radiation Therapy. An Illustrated Guide for Patients. BOOK HIGHLIGHTS: Starting with how radiation therapy works, Confessions of a Radiation Oncologist informs patients of what to expect before, during and after treatment. Special attention is... continue reading >>


Breast cancer linked to an imbalanced microbiome, research says


2018-04-17
Posted by: Lori Alton, staff writer in Science News , Stop Cancer Naturally April 17, 2018 0 ( Naturalhealth365 ) Breast cancer, second only to lung cancer as a cause of cancer deaths among women, is expected to claim the lives of over 40,000 women in 2017 alone. As researchers race to find better methods of preventing, detecting and treating this deadly disease, they are learning more about the vital role played by the microbiome – the body’s population of bacteria – in maintaining... continue reading >>


OncoDNA announces publication of peer-reviewed study in Oncotarget assessing the utility of its uniq


2018-04-17
Home OncoDNA announces publication of peer-reviewed study in Oncotarget assessing the utility of its uniq IMAGE: (A) Number of samples rejected and processed; (B) Patients with treatment options (approved for the cancer type analyzed, approved for other cancer types or under development) and without, according to... Image credit: Jean-François Laes, email: jf.laes@oncodna.com Gosselies, Belgium - April 17, 2018: OncoDNA ("OncoDNA or "the Company"), the healthcare technology company that... continue reading >>


OncoDNA announces publication of peer-reviewed study in Oncotarget assessing the utility of its unique biomarker analysis and interpretation platform in clinical decision making


2018-04-17
Public Release: 17-Apr-2018 OncoDNA announces publication of peer-reviewed study in Oncotarget assessing the utility of its unique biomarker analysis and interpretation platform in clinical decision making OncoDNA, the healthcare technology company that collates and translates complex cancer biomarker data to make precision medicine a reality, is pleased to announce the publication of a study in the journal Oncotarget evaluating Rapamycin Press IMAGE: (A) Number of samples rejected and... continue reading >>


Insilico to present the advances in Artificial Intelligence for Healthcare in Kenya


2018-04-17
Insilico to present the advances in Artificial Intelligence for Healthcare in Kenya InSilico Medicine, Inc. IMAGE: Iraneus Ogu, Africa AI, Blockchain and Longevity Consultant in Insilico Medicine, will present at the Kenya Medical Association 46th Annual Scientific Conference in Mombasa, Kenya, April 21, 2018. view more Credit: Insilico Medicine Tuesday, April 17th, 2018, Baltimore, MD - Insilico Medicine, a Baltimore-based company specializing in the application of artificial intelligence... continue reading >>


Could Some Iron Supplements Raise Your Risk of Colon Cancer?


2018-04-13
Could Some Iron Supplements Raise Your Risk of Colon Cancer? Posted on Dept of Biology and Biological Engineering Food and Nutrition Science Göteborg, Sweden What are Many different forms of iron supplements are used to treat iron deficiency symptoms or as phosphate binders in patients with renal disease. two of these iron supplements, the chelates ferric citrate and ferric EDTA have been observed to drive colon cancer in mice. In the newly published study in Oncotarget, we are... continue reading >>


Popular iron supplements taken by million 'may trigger bowel cancer'


2018-04-12
Iron tablets taken by millions of people could trigger bowel cancer, warns new research. Two chemicals commonly found in the supplements may fuel the development of tumours, according to a study. The popular pills have been linked to an increased risk of the disease for more than 20 years. Now experiments on human cells grown in the lab have found they boost a molecule linked to the deadliest forms. About six million prescriptions for iron tablets are issued each year in England and Wales... continue reading >>


Results from an ongoing phase II study of isolated thoracic perfusion with chemofiltration for pleural mesothelioma


2018-04-11
Results from an ongoing phase II study of isolated thoracic perfusion with chemofiltration for pleural mesothelioma Scheme of Isolated Thoracic Perfusion with Chemofiltration (ITP-F) Favorable results from an ongoing study of regional chemotherapy for pleural mesothelioma presented at the 59th Congress of the German Society for Pneumology BURGHAUSEN, GERMANY, April 11, 2018 / EINPresswire.com / -- Medias Klinikum GmbH & Co KG, a private hospital specialized in surgical oncology, focusing on... continue reading >>


Cell biologist, experienced in molecular & histological techniques. resume in Atlanta, GA - April 2018


2018-04-09
- Candidate for PhD in Integrative Bioscience, cGPA=4.00 - Masters in Biology, cGPA=4.00 - Bachelor’s degree in Clinical Laboratory Science(CLS), cGPA 3.76 WORK EXPERINECE: 09/2009 – 10/2012 Graduate Teaching and Research Assistant at the Pathology and Molecular Biology unit, Department of CLS, ACHS, University of Asmara, Asmara, Eritrea. 10/2006 – 08/2010 - Part Time Laboratory Scientist at National Health Laboratory of Eritrea, Asmara, Eritrea 08/2014-Present: Graduate Teaching... continue reading >>


Gene Therapy Could Be Key To Survival Of Astronauts In Deep Space Mission To Mars


2018-04-08
Gene Therapy Could Be Key To Survival Of Astronauts In Deep Space Mission To Mars 8 April 2018, 7:38 am EDT By Allan Adamson Tech Times High-dose radiation in space could be deadly for astronauts on a mission to planet Mars. What are ways through which gene therapy can increase their odds of survival? ( NASA ) Radiation is one of the major problems in space travel . Astronauts receive high doses of radiation beyond Earth's magnetic field and atmosphere, and it could elevate their risk of... continue reading >>


Insilico to present the latest developments in AI for aging biomarkers and age management research


2018-04-06
Insilico to present the latest developments in AI for aging biomarkers and age management research InSilico Medicine, Inc. IMAGE: Insilico Medicine presents at the 24th Clinical Applications for Age Management Medicine Conference. view more Credit: Insilico Medicine Friday, April 6th, 2018, Baltimore, MD - Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery, biomarker development and aging... continue reading >>


Insilico to present the advances in AI for biomarker development of human aging


2018-04-04
Insilico to present the advances in AI for biomarker development of human aging InSilico Medicine, Inc. IMAGE: Alexander Zhebrak, CTO of Insilico Medicine, will present the advances in biomarker development of human aging at the International Conference on Interventions to Extend Healthspan and Lifespan. view more Credit: Insilico Medicine Wednesday, April 4th, 2018, Baltimore, MD - Insilico Medicine, a Baltimore-based company specializing in the application of artificial intelligence for... continue reading >>


CohBar, Inc. Announces Fourth Quarter 2017 Financial Results


2018-04-02
CohBar, Inc. Announces Fourth Quarter 2017 Financial Results April 02, 2018 16:03 ET | Source: CohBar, Inc. MENLO PARK, Calif., CohBar, Inc. (NASDAQ: CWBR ) (TSXV:COB.U) (“CohBar” or the “Company”), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported its financial results for the fourth quarter ended December 31, 2017. “We continue to progress CB4211 toward a mid-year clinical entry for our Phase... continue reading >>



Copyright © 2018 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC